Quest Diagnostics Inc Equity Securities, FV-NI and without Readily Determinable Fair Value
Quest Diagnostics Inc (DGX) had Equity Securities, FV-NI and without Readily Determinable Fair Value of $25.00 million as of 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Notes › Investments
us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue · last filed 2020-02-20
- 2019-12-31: Equity Securities, FV-NI and without Readily Determinable Fair Value $25.00M.
- 2018-12-31: Equity Securities, FV-NI and without Readily Determinable Fair Value $10.00M.
| Period end | Equity Securities, FV-NI and without Readily Determinable Fair Value |
|---|---|
| 2019-12-31 | $25.00M 10-K · filed 2020-02-20 |
| 2018-12-31 | $10.00M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |